PT858324E - Processo de granulacao aquosa da claritromicina - Google Patents

Processo de granulacao aquosa da claritromicina

Info

Publication number
PT858324E
PT858324E PT96937699T PT96937699T PT858324E PT 858324 E PT858324 E PT 858324E PT 96937699 T PT96937699 T PT 96937699T PT 96937699 T PT96937699 T PT 96937699T PT 858324 E PT858324 E PT 858324E
Authority
PT
Portugal
Prior art keywords
claritromycin
aqueous granulation
granulation process
macrolide antibiotic
carbomer
Prior art date
Application number
PT96937699T
Other languages
English (en)
Inventor
Azita Saleki-Gerhard
Ernest R Keske
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of PT858324E publication Critical patent/PT858324E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT96937699T 1995-11-01 1996-10-18 Processo de granulacao aquosa da claritromicina PT858324E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US715095P 1995-11-01 1995-11-01
US08/722,288 US5919489A (en) 1995-11-01 1996-10-09 Process for aqueous granulation of clarithromycin
PCT/US1996/016794 WO1997016174A1 (en) 1995-11-01 1996-10-18 Process for aqueous granulation of clarithromycin

Publications (1)

Publication Number Publication Date
PT858324E true PT858324E (pt) 2003-10-31

Family

ID=26676595

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96937699T PT858324E (pt) 1995-11-01 1996-10-18 Processo de granulacao aquosa da claritromicina

Country Status (13)

Country Link
US (1) US5919489A (pt)
EP (1) EP0858324B1 (pt)
JP (1) JP4334015B2 (pt)
KR (1) KR100524202B1 (pt)
AT (1) ATE241963T1 (pt)
AU (1) AU706837B2 (pt)
CA (1) CA2235607C (pt)
DE (1) DE69628575T2 (pt)
DK (1) DK0858324T3 (pt)
ES (1) ES2200075T3 (pt)
IL (1) IL123571A (pt)
PT (1) PT858324E (pt)
WO (1) WO1997016174A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6551616B1 (en) 1997-04-11 2003-04-22 Abbott Laboratories Extended release formulations of erythromycin derivatives
US6010718A (en) * 1997-04-11 2000-01-04 Abbott Laboratories Extended release formulations of erythromycin derivatives
IN191239B (pt) 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
CZ20014379A3 (cs) * 1999-06-11 2002-08-14 Ranbaxy Laboratories Limited Kompozice k maskování chuti a způsob její přípravy
AU1169601A (en) * 1999-11-16 2001-05-30 Ranbaxy Laboratories Limited Taste masked oral compositions
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6617436B2 (en) * 2000-02-29 2003-09-09 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
WO2001072284A1 (en) * 2000-03-28 2001-10-04 Biochemie Gesellschaft M.B.H. Granulated particles with masked taste
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
DE10133546A1 (de) * 2001-07-11 2003-03-06 Petra Bastian Mischkomplexe zur Maskierung bitter schmeckender Substanzen
FR2827517B1 (fr) 2001-07-23 2003-10-24 Bioalliance Pharma Systemes therapeutiques bioadhesifs a liberation prolongee
DK1411899T3 (da) * 2001-08-01 2009-06-02 Novartis Ag Smagsmaskerende sammensætning
US20040043073A1 (en) * 2002-06-14 2004-03-04 Chih-Ming Chen Pharmaceutical compositions for drugs having pH-dependent solubility
US20060083759A1 (en) * 2002-07-17 2006-04-20 Aleksander Resman Stabilization of the profile of release of active substances from a formulation
EP1417958A1 (en) * 2002-11-08 2004-05-12 Pari GmbH Wet granulation process
PL1638529T3 (pl) * 2003-06-16 2017-03-31 Andrx Pharmaceuticals, Llc. Kompozycja doustna o przedłużonym uwalnianiu
EP1648407A4 (en) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528185A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004264939A1 (en) 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
JP2007502294A (ja) 2003-08-12 2007-02-08 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
CA2535780A1 (en) 2003-08-29 2005-03-17 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
ATE399536T1 (de) * 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
CA2547773A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
KR20060092281A (ko) * 2003-12-04 2006-08-22 화이자 프로덕츠 인크. 액체 기초 방법에 의한 아지트로마이신 복합입자 투여형
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
CN1883456B (zh) * 2005-06-20 2010-12-15 常州市第四制药厂有限公司 掩味药物颗粒及其制备方法和用途
EP1904041A2 (en) * 2005-07-07 2008-04-02 Elan Pharma International Limited Nanoparticulate clarithromycin formulations
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
EP1837020A1 (en) 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20070286903A1 (en) * 2006-06-13 2007-12-13 Becicka Brian T Composition and method for taste masking
EP2030613A1 (en) * 2007-08-17 2009-03-04 Abbott GmbH & Co. KG Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics
WO2012091039A1 (ja) * 2010-12-27 2012-07-05 富田製薬株式会社 粒子状製剤
CN102813633A (zh) * 2011-06-10 2012-12-12 塔科敏斯基制药厂波尔法合资公司 用湿法制粒制备包含大环内酯类抗生素的药物组合物的方法
RU2692469C1 (ru) * 2018-06-25 2019-06-25 ООО "Новые Антибиотики" Лекарственное средство для лечения и предупреждения возникновения осложнений, связанных с химиотерапией и рентгенотерапией, а также состояний, связанных с повышенной проницаемостью кишки
JP7442193B2 (ja) * 2018-08-10 2024-03-04 日本臓器製薬株式会社 粒状組成物及びその製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4608278A (en) * 1983-06-22 1986-08-26 The Ohio State University Research Foundation Small particule formation and encapsulation
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions

Also Published As

Publication number Publication date
EP0858324A1 (en) 1998-08-19
AU706837B2 (en) 1999-06-24
ES2200075T3 (es) 2004-03-01
JP4334015B2 (ja) 2009-09-16
IL123571A0 (en) 1998-10-30
WO1997016174A1 (en) 1997-05-09
EP0858324B1 (en) 2003-06-04
DE69628575T2 (de) 2004-04-29
DE69628575D1 (de) 2003-07-10
KR19990067265A (ko) 1999-08-16
CA2235607A1 (en) 1997-05-09
AU7517696A (en) 1997-05-22
JPH11514646A (ja) 1999-12-14
MX9803480A (es) 1998-09-30
KR100524202B1 (ko) 2006-07-06
CA2235607C (en) 2003-05-13
DK0858324T3 (da) 2003-09-29
IL123571A (en) 2005-07-25
ATE241963T1 (de) 2003-06-15
US5919489A (en) 1999-07-06

Similar Documents

Publication Publication Date Title
PT858324E (pt) Processo de granulacao aquosa da claritromicina
DK0915898T3 (da) Krystalform I af clarithromycin
NO981150L (no) Konsentrert, flytende vaskemiddelblanding og fremgangsmÕte for fremstilling av denne
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
ATA49296A (de) Zementspritzmischung
ES2166010T3 (es) Produccion de acrilato de amonio.
BR9205854A (pt) Composiçoes de mistura curavel por UV e processos.
DE69425534D1 (de) Mischverfahren zur Formulierung von Detergentien
PT912576E (pt) Processo de sintese de antibioticos carbapenem.
BR9610520A (pt) Processo para produção conjunta de amônia e metanol
BR9610519A (pt) Processo para produção conjunta de amônia e metanol
BR9813079A (pt) Processo para a preparação de um antibiótico beta-lactama
BR9811334A (pt) Processo para preparação e/ou purificação de amido ácido fenil éster sulfonatos
DE69632135D1 (de) Prozess zur hydrierenden entschwefelung.
BR9101118A (pt) Produto contendo um ou mais veiculos de enzimas e anticorpos ou fragmentos de anticorpos,e processo para atacar um alvo
ES2122647T3 (es) Granulado polienzimatico asi como su fabricacion.
PT633928E (pt) Microrganismos processo de preparacao e utilizacao
PT102202A (pt) Processo para a purificacao de roxitromicina
BR9710386B1 (pt) processo de preparação de um composto e processo de transformação do composto.
FR2714727B1 (fr) Procédé de navigation terrestre.
BR9712690A (pt) Processo para a preparação de ivermectina
FR2722131B1 (fr) Procede de preparation de melanges aqueux agrileux pompables
BR9914775A (pt) Processo quìmico para preparação deintermediários
CA2193932A1 (en) Process for producing isatoic anhydrides
BR9303174A (pt) Processo de tratamento de elfuentes líquidos orgânicos utilizando-se oxigênio puro pelo sistema de aerador modificado